Literature DB >> 26578092

Sizing the optimal dimensions of a vaccine delivery system: a particulate matter.

Bram Slütter1, Wim Jiskoot2.   

Abstract

Encapsulation of subunit antigens into particulate vaccine delivery systems is a promising strategy to enhance their immunogenicity. The most basic physical parameter of these particles, their size, has a profound effect on the immunogenicity of the vaccine. Interestingly, the optimal particle size varies depending on the desired type of immunological memory and the route of administration. In this editorial, we draw attention to the effect of particle size on the resulting immune response and accentuate the importance of adequate particle sizing methods, within and beyond the intended size range of the delivery vehicle, to assess vaccine quality.

Keywords:  Microparticles; nanoparticles; particle characterization; particle size; vaccine delivery

Mesh:

Substances:

Year:  2015        PMID: 26578092     DOI: 10.1517/17425247.2016.1121989

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  12 in total

1.  Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.

Authors:  Berrin Küçüktürkmen; Jessica M Rosenholm
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Characterization and Protective Efficacy of Type III Secretion Proteins as a Broadly Protective Subunit Vaccine against Salmonella enterica Serotypes.

Authors:  Francisco J Martinez-Becerra; Prashant Kumar; Vikalp Vishwakarma; Jae Hyun Kim; Olivia Arizmendi; C Russell Middaugh; William D Picking; Wendy L Picking
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

Authors:  Bala V K Karuturi; Shailendra B Tallapaka; Pravin Yeapuri; Stephen M Curran; Sam D Sanderson; Joseph A Vetro
Journal:  Mol Pharm       Date:  2017-04-03       Impact factor: 4.939

Review 4.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

Review 5.  Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.

Authors:  Wim Jiskoot; Grzegorz Kijanka; Theodore W Randolph; John F Carpenter; Atanas V Koulov; Hanns-Christian Mahler; Marisa K Joubert; Vibha Jawa; Linda O Narhi
Journal:  J Pharm Sci       Date:  2016-04-01       Impact factor: 3.534

Review 6.  Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Expert Opin Drug Deliv       Date:  2020-10-06       Impact factor: 8.129

7.  Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering.

Authors:  Martti Kaasalainen; Vladimir Aseyev; Eva von Haartman; Didem Şen Karaman; Ermei Mäkilä; Heikki Tenhu; Jessica Rosenholm; Jarno Salonen
Journal:  Nanoscale Res Lett       Date:  2017-01-25       Impact factor: 4.703

Review 8.  Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy.

Authors:  Julia Koerner; Dennis Horvath; Marcus Groettrup
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 9.  Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.

Authors:  Yong Gao; Chanuka Wijewardhana; Jamie F S Mann
Journal:  Front Immunol       Date:  2018-02-28       Impact factor: 7.561

Review 10.  Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design.

Authors:  Ximena Zottig; Mélanie Côté-Cyr; Dominic Arpin; Denis Archambault; Steve Bourgault
Journal:  Nanomaterials (Basel)       Date:  2020-05-25       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.